References
- Yeo JT, Storm CA, et al. Performance of the enhanced Abbott AxSYM cardiac troponin reagent in patients with heterophile antibodies. Clin Chim Acta 2000;292:13-23.
- Boerman OC, Segers MFG, et al. Heterophilic antibodies in human sera causing falsely increased results in the CA 125 immunofluorometic assay. Clin Chem 1990;36:888-91.
- Turpeinen U, Lehtovirta P, Stenman U. CA 125 determined by three methods in samples from patients with human anti-mouse antibodies (HAMA). Clin Chem 1995;41:1667-9.
- Cole LA, Rinne KM, Shahabi S, Omrani A. False positive hCG assay results leading to unnecessary surgery and chemotherapy and needless occurrences of diabetes and coma. Clin Chem 1999;45:313-4.
- Reinsberg J. Interference of human antibodies with tumor marker assays. Hybridoma 1995;14:205-8.
- Klee, GG. Human anti-mouse antibodies. Arch Pathol Lab Med 2000;124:921-3.
- Lipp RW, Passath A, Leb G. The incidence of non-iatrogenic human anti-mouse antibodies and their possible clinical relevance. Eur J Nucl Med 1991; 18:996-8.
- Reinsberg J. Interference by human antibodies with tumor marker assays. Hybridoma 1995;14:205-8.
- Dillman RO, Shawler DL, McCallister V, Halpern SE. Human anti-mouse antibody response in cancer patients following single low-dose injections of radiolabeled murine monoclonal antibodies. Cancer Biother 1994;9:17-28.
- Legouffe E, Liautard J, Gaillard JP, et al. Human antimouse antibody response to the injection of murine monoclonal antibodies against IL-6. Clin Exp Immunol 1994;98:323-9.
- Lucas GF, Rogers SE.Evaluation of an enzyme linked immunosorbent assay kit (GTI Pak Plus) for the detection of antibodies against human platelet antigens.Transfus Med 1999;9:63-7.